The trend of accurate pathology diagnosis of breast cancer.
10.3760/cma.j.cn112151-20230727-00030
- VernacularTitle:乳腺癌病理精准诊断发展的方向
- Author:
Y P LIU
1
;
W T YANG
2
;
H BU
3
Author Information
1. Department of Pathology, the Fourth Hospital of Hebei Medical University, Tumor Hospital of Hebei Province, Shijiazhuang 050011, China.
2. Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
3. Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China.
- Publication Type:Review
- MeSH:
Female;
Humans;
Artificial Intelligence;
Breast;
Breast Neoplasms;
Immunotherapy;
Neoadjuvant Therapy
- From:
Chinese Journal of Pathology
2023;52(9):885-890
- CountryChina
- Language:Chinese
-
Abstract:
Accurate pathology diagnosis of breast cancer is the premise of personalized treatment. In recent years, the pathology diagnosis of breast cancer have been updated and optimized to provide better guidance and basis for clinical treatment. In this paper, we provide an overview on the advances in histological classification of breast cancer, the progress of biomarker detection related to novel antibody-drug conjugates and immunotherapy in breast cancer, the pathology evaluation of breast cancer specimen after neoadjuvant therapy and sentinel lymph nodes, the progress of genetic testing in breast cancer, and the application of artificial intelligence in breast pathology.
